Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Chapman

Showing results (251-260 of 320) with videos related to

Pageof 32
Sort By:
Atherosclerosis|June 23, 2017
Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURNRishi Puri, Christie M Ballantyne, Ron C Hoogeveen, et al.
The New England Journal of Medicine|December 14, 2016
Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and DiabetesBrian A Ference, Jennifer G Robinson, Robert D Brook, et al.
European Heart Journal|October 30, 2016
European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular riskUlf Landmesser, M. John Chapman, Michel Farnier, et al.
Atherosclerosis|December 3, 2014
Altered lipidome and antioxidative activity of small, dense HDL in normolipidemic rheumatoid arthritis: relevance of inflammationLeonardo Gómez Rosso, Marie Lhomme, Tomas Meroño, et al.
Journal of Lipid Research|October 22, 2015
Statin action favors normalization of the plasma lipidome in the atherogenic mixed dyslipidemia of MetS: potential relevance to statin-associated dysglycemiaPeter J Meikle, Gerard Wong, Ricardo Tan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 5, 2009
Stimulation of cholesterol efflux by LXR agonists in cholesterol-loaded human macrophages is ABCA1-dependent but ABCG1-independentSandra Larrede, Carmel M Quinn, Wendy Jessup, et al.
European Heart Journal|May 7, 2013
Factors underlying regression of coronary atheroma with potent statin therapyRishi Puri, Steven E Nissen, Christie M Ballantyne, et al.
Circulation Research|October 31, 2007
Coexistence of foam cells and hypocholesterolemia in mice lacking the ABC transporters A1 and G1Ruud Out, Wendy Jessup, Wilfried Le Goff, et al.
European Heart Journal. Cardiovascular Imaging|January 23, 2014
Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURNRishi Puri, Peter Libby, Steven E Nissen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 30, 2011
Atheroprotective reverse cholesterol transport pathway is defective in familial hypercholesterolemiaNatacha Bellanger, Alexina Orsoni, Zélie Julia, et al.
Pageof 32

Showing results (251-260 of 320) with videos related to

Sort By:
Pageof 32
Atherosclerosis|June 23, 2017
Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURNRishi Puri, Christie M Ballantyne, Ron C Hoogeveen, et al.
The New England Journal of Medicine|December 14, 2016
Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and DiabetesBrian A Ference, Jennifer G Robinson, Robert D Brook, et al.
European Heart Journal|October 30, 2016
European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular riskUlf Landmesser, M. John Chapman, Michel Farnier, et al.
Atherosclerosis|December 3, 2014
Altered lipidome and antioxidative activity of small, dense HDL in normolipidemic rheumatoid arthritis: relevance of inflammationLeonardo Gómez Rosso, Marie Lhomme, Tomas Meroño, et al.
Journal of Lipid Research|October 22, 2015
Statin action favors normalization of the plasma lipidome in the atherogenic mixed dyslipidemia of MetS: potential relevance to statin-associated dysglycemiaPeter J Meikle, Gerard Wong, Ricardo Tan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 5, 2009
Stimulation of cholesterol efflux by LXR agonists in cholesterol-loaded human macrophages is ABCA1-dependent but ABCG1-independentSandra Larrede, Carmel M Quinn, Wendy Jessup, et al.
European Heart Journal|May 7, 2013
Factors underlying regression of coronary atheroma with potent statin therapyRishi Puri, Steven E Nissen, Christie M Ballantyne, et al.
Circulation Research|October 31, 2007
Coexistence of foam cells and hypocholesterolemia in mice lacking the ABC transporters A1 and G1Ruud Out, Wendy Jessup, Wilfried Le Goff, et al.
European Heart Journal. Cardiovascular Imaging|January 23, 2014
Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURNRishi Puri, Peter Libby, Steven E Nissen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 30, 2011
Atheroprotective reverse cholesterol transport pathway is defective in familial hypercholesterolemiaNatacha Bellanger, Alexina Orsoni, Zélie Julia, et al.
Pageof 32